Lv11
48 积分 2023-05-09 加入
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
2小时前
待确认
What are the current trends in G protein-coupled receptor targeted drug discovery?
2个月前
已完结
Vaccine Therapy for Heart Failure Targeting the Inflammatory Cytokine Igfbp7
3个月前
已完结
Report of the European Medicines Agency Conference on RNA-Based Medicines
6个月前
已完结
Isothermal titration calorimetry
6个月前
已完结
Novel drug targets in 2023
6个月前
已完结
A Novel Dual-Fc Bispecific Antibody with Enhanced Fc Effector Function
6个月前
已完结
Discovery of Highly Potent Small-Molecule PD-1/PD-L1 Inhibitors with a Novel Scaffold for Cancer Immunotherapy
6个月前
已完结
Manufacturing chimeric antigen receptor T cells: issues and challenges
7个月前
已完结
Global Manufacturing of CAR T Cell Therapy
7个月前
已完结
皖公网安备34019202002308
